Hostname: page-component-cd9895bd7-mkpzs Total loading time: 0 Render date: 2024-12-22T16:38:17.602Z Has data issue: false hasContentIssue false
  • English
  • Français

Marked improvement in tardive dyskinesia following treatment with olanzapine in an elderly subject

Published online by Cambridge University Press:  02 January 2018

J. O'Brien  and
R. Barber
J. O'Brien
Affiliation:
Department of Psychiatry and Institute of Health of the Elderly, University of Newcastle upon Tyne, Castleside Unit, Newcastle General Hospital, Newcastle upon Tyne NE4 6BE
R. Barber
Affiliation:
Department of Psychiatry and Institute of Health of the Elderly, University of Newcastle upon Tyne, Castleside Unit, Newcastle General Hospital, Newcastle upon Tyne NE4 6BE
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Information
The British Journal of Psychiatry , Volume 172 , Issue 2 , February 1998 , pp. 186
Copyright
Copyright © 1998 The Royal College of Psychiatrists 

References

American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM–IV). Washington. DC: APA.Google Scholar
Anonymous (1997) A novel atypical neuroleptic agent. Lancet, 349, 1264.Google Scholar
Folstein, M. F. Folstein, S. E. & McHugh, P. R. (1975) ‘Mini-Mental State’: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.CrossRefGoogle Scholar
Lieberman, J. A. Saltz, B. L. Johns, C. A. et al (1991) The effects of clozapine on tardive dyskinesia. British Journal of Psychiatry, 158, 503–510.Google Scholar
Pilowsky, L. S. Acton, P. D. Costa, D. C. et al (1997) Limbic selectivity of clozapine. Lancet, 350, 490–491.Google Scholar
Toliefson, G. D. Beasley, C. M. Graffeo, K. A. et al (1997) Olanzapine versus haloperidol in the treatment of schizophrenia and schizophreniform disorders: results of an international collaborative trial. American Journal of Psychiatry, 154, 457–465.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.